ePoster

Switch To Module

Conference Calendar
ePoster
Name Search

GENERAL SEARCH

GENERAL SEARCH
Session Title
Title
Abstract
Role Authors
Presenter

Filter By

Day

Select AllDeselect All
Tue, 05.03.2024125
Wed, 06.03.2024711
Thu, 07.03.202454
Fri, 08.03.2024690

Room

Select AllDeselect All
On-Demand Oral Gallery98
ON-DEMAND VIRTUAL GALLERY1482

Session Name

Select AllDeselect All
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.A. DISEASE MECHANISMS, PATHOPHYSIOLOGY: ABETA AGGREGATION, PROTEIN MISFOLDING7
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.B. DISEASE MECHANISMS, PATHOPHYSIOLOGY: CELL TO CELL TRANSMISSION, SPREADING OF PATHOLOGY, PRION-LIKE2
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.C. DISEASE MECHANISMS, PATHOPHYSIOLOGY: INFLAMMATION19
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.D. DISEASE MECHANISMS, PATHOPHYSIOLOGY: SYNAPTIC PLASTCITY & SYNAPSE PATHOLOGY4
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.E. DISEASE MECHANISMS, PATHOPHYSIOLOGY: CELLULAR SIGNALLING, KINASES, PHOSPHATASES, CALCIUM3
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.F. DISEASE MECHANISMS, PATHOPHYSIOLOGY: LYSOSOMES, UBIQUITIN, PROTEASOME, ER STRESS, CHAPERONES2
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.G. DISEASE MECHANISMS, PATHOPHYSIOLOGY: MITOCHONDRIAL DYSFUNCTION, OXIDATIVE DAMAGE7
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.H. DISEASE MECHANISMS, PATHOPHYSIOLOGY: LIPIDS, LIPOPROTEINS AND MEMBRANE TRAFFICKING3
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.I. DISEASE MECHANISMS, PATHOPHYSIOLOGY: MICROGLIA13
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.J. DISEASE MECHANISMS, PATHOPHYSIOLOGY: ASTROGLIA6
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.K. DISEASE MECHANISMS, PATHOPHYSIOLOGY: NEUROGENESIS1
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.L. DISEASE MECHANISMS, PATHOPHYSIOLOGY: VASCULATURE, MICROBLEEDS, HYPERTENSION, ANGIOGENESIS1
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.M. DISEASE MECHANISMS, PATHOPHYSIOLOGY: BLOOD-BRAIN BARRIER5
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.N. DISEASE MECHANISMS, PATHOPHYSIOLOGY: METABOLISM, INSULIN4
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.O. DISEASE MECHANISMS, PATHOPHYSIOLOGY: NEURAL NETWORKS, PLASTICITY2
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.P. DISEASE MECHANISMS, PATHOPHYSIOLOGY: TRANSCRIPTIONAL & TRANSLATIONAL REGULATION, MICRO RNAS3
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.Q. DISEASE MECHANISMS, PATHOPHYSIOLOGY: AUTOPHAGY, APOPTOSIS, CELL DEATH3
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.R. DISEASE MECHANISMS, PATHOPHYSIOLOGY: AGING4
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A01.S. DISEASE MECHANISMS, PATHOPHYSIOLOGY: MICROBIOME4
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A02.A. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: ABETA, TRUNCATED & PGLU-ABETA3
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A02.B. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: IMMUNOTHERAPY5
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A02.C. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: SECRETASES, PROTEASES3
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A02.E. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: NEUROTRANSMITTERS & RECEPTOR-BASED1
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A02.F. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: APOE & LIPOPROTEIN-BASED1
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A02.G. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: ANTI-INFLAMMATORY4
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A02.I. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: NEUROTROPHIC, SYNAPTIC PLASTICITY, REPAIR, REGENERATIVE MEDICINE2
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A02.J. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: PROTEIN AGGREGATION, MISFOLDING, CHAPERONES2
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A02.K. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: TREM23
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A02.M. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: MICROGLIA3
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A02.O. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: GENE THERAPY AND GENE EDITING3
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A02.P. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: ASO AND RNAI1
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A02.Q. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: OTHER5
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A03.A. DRUG DEVELOPMENT, CLINICAL TRIALS: IMMUNOTHERAPY1
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A03.B. DRUG DEVELOPMENT, CLINICAL TRIALS: AMYLOID CLEARANCE4
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A03.E. DRUG DEVELOPMENT, CLINICAL TRIALS: NEUROPROTECTIVE & MITOCHONDRIAL COMPOUNDS1
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A03.F. DRUG DEVELOPMENT, CLINICAL TRIALS: NEUROTRANSMITTER-BASED MODULATORS1
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A03.H. DRUG DEVELOPMENT, CLINICAL TRIALS: MEDICINAL CHEMISTRY APPROACHES, DRUG REPURPOSING1
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A03.K. DRUG DEVELOPMENT, CLINICAL TRIALS: NON-PHARMACOLOGICAL INTERVENTIONS3
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A03.L. DRUG DEVELOPMENT, CLINICAL TRIALS: REGULATORY ASPECTS, OTHER1
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A04.A. IMAGING, BIOMARKERS, DIAGNOSTICS: STRUCTURAL MRI, MR SPECTROSCOPY6
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A04.B. IMAGING, BIOMARKERS, DIAGNOSTICS: FUNCTIONAL MRI3
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A04.C. IMAGING, BIOMARKERS, DIAGNOSTICS: PET - THEME A: Β-AMYLOID DISEASES / AMYLOID7
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A04.D. IMAGING, BIOMARKERS, DIAGNOSTICS: PET - THEME G: HUNTINGTON'S AND OTHER NEURODEGENERATIVE DISEASES / GLUCOSE2
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A04.E. IMAGING, BIOMARKERS, DIAGNOSTICS: PET - OTHER2
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A04.F. IMAGING, BIOMARKERS, DIAGNOSTICS: MULTIMODAL IMAGING7
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A04.G. IMAGING, BIOMARKERS, DIAGNOSTICS: CSF, BLOOD, BODY FLUID BIOMARKERS37
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A04.H. IMAGING, BIOMARKERS, DIAGNOSTICS: EEG, BRAIN MAPPING, MEG10
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A04.I. IMAGING, BIOMARKERS, DIAGNOSTICS: COGNITIVE, PSYCHOMETRIC & BEHAVIORAL TESTS, DIGITAL ENDPOINTS, REMOTE TESTING13
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A04.J. IMAGING, BIOMARKERS, DIAGNOSTICS: OTHER6
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A05.A. GENETICS, EPIDEMIOLOGY: WHOLE GENOME SEQUENCING2
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A05.B. GENETICS, EPIDEMIOLOGY: DISEASE-CAUSING MUTATIONS2
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A05.C. GENETICS, EPIDEMIOLOGY: GWAS, GENETIC ASSOCIATIONS, SUSCEPTIBILITY & PROTECTIVE GENES12
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A05.D. GENETICS, EPIDEMIOLOGY: AGING1
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A05.E. GENETICS, EPIDEMIOLOGY: ENVIRONMENTAL RISK FACTORS4
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A05.G. GENETICS, EPIDEMIOLOGY: INFECTIOUS AND INFLAMMATION2
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A05.H. GENETICS, EPIDEMIOLOGY: OTHER5
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A06.A. CELL, MOLECULAR AND SYSTEMS BIOLOGY: APP, APLP, ABETA4
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A06.D. CELL, MOLECULAR AND SYSTEMS BIOLOGY: NETWORK BIOLOGY, CONNECTOME, PROTEIN-PROTEIN INTERATIONS3
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A06.E. CELL, MOLECULAR AND SYSTEMS BIOLOGY: METABOLOMICS, TRANSCRIPTOMICS, LIPIDOMICS, PROTEOMICS10
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A06.F. CELL, MOLECULAR AND SYSTEMS BIOLOGY: EPIGENETICS, HISTONE MODIFICATION, DNA METHYLATION1
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A06.G. CELL, MOLECULAR AND SYSTEMS BIOLOGY: OTHER6
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A07.A. ANIMAL MODELS: TRANSGENIC RODENTS7
POSTER SHIFT 01 (MARCH 6-7): THEME A: Β-AMYLOID DISEASES / A07.B. ANIMAL MODELS: PRIMATES, NATURALLY OCCURING MODELS AND BRAIN ORGANOIDS2
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B01.A. DISEASE MECHANISMS, PATHOPHYSIOLOGY: TAU AGGREGATION, PHOPHORYLATION, ACETYLATION & MODIFICATIONS8
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B01.C. DISEASE MECHANISMS, PATHOPHYSIOLOGY: INFLAMMATION4
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B01.D. DISEASE MECHANISMS, PATHOPHYSIOLOGY: SYNAPSE PATHOLOGY4
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B01.E. DISEASE MECHANISMS, PATHOPHYSIOLOGY: CELLULAR SIGNALLING, KINASES, PHOSPHATASES, CALCIUM1
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B01.F. DISEASE MECHANISMS, PATHOPHYSIOLOGY: LYSOSOMES, UBIQUITIN, PROTEASOME, ER STRESS1
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B01.G. DISEASE MECHANISMS, PATHOPHYSIOLOGY: MITOCHONDRIAL DYSFUNCTION, OXIDATIVE DAMAGE1
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B01.J. DISEASE MECHANISMS, PATHOPHYSIOLOGY: BLOOD-BRAIN BARRIER1
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B01.K. DISEASE MECHANISMS, PATHOPHYSIOLOGY: METABOLISM, INSULIN4
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B01.L. DISEASE MECHANISMS, PATHOPHYSIOLOGY: NEURAL NETWORKS & PLASTICITY1
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B01.N. DISEASE MECHANISMS, PATHOPHYSIOLOGY: AUTOPHAGY, APOPTOSIS, CELL DEATH1
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B01.O. DISEASE MECHANISMS, PATHOPHYSIOLOGY: AGING1
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B01.P. DISEASE MECHANISMS, PATHOPHYSIOLOGY: OTHER6
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B02.A. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: TAU, PHOSPHORYLATION, TRUNCATION4
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B02.B. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: IMMUNOTHERAPY3
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B02.D. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: NEUROTRANSMITTERS & RECEPTOR-BASED1
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B02.F. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: PROTEIN AGGREGATION, NFT, MISFOLDING, CHAPERONES2
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B02.G. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: GENE AND RNAI THERAPY2
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B02.H. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: MICROGLIA2
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B02.I. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: OTHER5
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B03.A. DRUG DEVELOPMENT, CLINICAL TRIALS: IMMUNOTHERAPY1
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B03.B. DRUG DEVELOPMENT, CLINICAL TRIALS: TAU CLEARANCE1
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B03.C. DRUG DEVELOPMENT, CLINICAL TRIALS: AGGREGATION INHIBITORS2
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B04.B. IMAGING, BIOMARKERS, DIAGNOSTICS: PET - TAU4
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B04.D. IMAGING, BIOMARKERS, DIAGNOSTICS: MULTIMODAL IMAGING2
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B04.E. IMAGING, BIOMARKERS, DIAGNOSTICS: CSF, BLOOD, BODY FLUID BIOMARKERS6
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B04.H. IMAGING, BIOMARKERS, DIAGNOSTICS: OTHER4
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B05.I. GENETICS, EPIDEMIOLOGY: OTHER3
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B06.A. CELL, MOLECULAR AND SYSTEMS BIOLOGY: TAU, TAU ISOFORMS3
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B06.C. CELL, MOLECULAR AND SYSTEMS BIOLOGY: NETWORK BIOLOGY, CONNECTOME, PROTEIN-PROTEIN INTERATIONS1
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B06.D. CELL, MOLECULAR AND SYSTEMS BIOLOGY: METABOLOMICS, TRANSCRIPTOMICS, LIPIDOMICS, PROTEOMICS3
POSTER SHIFT 01 (MARCH 6-7): THEME B: TAUPATHIES / B07.A. ANIMAL MODELS: TRANSGENIC RODENTS2
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C01.A. DISEASE MECHANISMS, PATHOPHYSIOLOGY: A-SYNUCLEIN AGGREGATION14
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C01.B. DISEASE MECHANISMS, PATHOPHYSIOLOGY: LRKK2, PARKIN, PINK1, DJ-15
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C01.C. DISEASE MECHANISMS, PATHOPHYSIOLOGY: CELL TO CELL TRANSMISSION, SPREADING OF PATHOLOGY, PRION-LIKE3
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C01.D. DISEASE MECHANISMS, PATHOPHYSIOLOGY: AUTOPHAGY, LYSOSOMES, UBIQUITIN, PROTEASOME1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C01.E. DISEASE MECHANISMS, PATHOPHYSIOLOGY: LIPIDS, LIPOPROTEINS AND MEMBRANE TRAFFICKING1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C01.F. DISEASE MECHANISMS, PATHOPHYSIOLOGY: INFLAMMATION2
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C01.G. DISEASE MECHANISMS, PATHOPHYSIOLOGY: MICROGLIA4
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C01.H. DISEASE MECHANISMS, PATHOPHYSIOLOGY: ASTROGLIA1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C01.I. DISEASE MECHANISMS, PATHOPHYSIOLOGY: CELLULAR SIGNALLING, KINASES, PHOSPHATASES, CALCIUM1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C01.J. DISEASE MECHANISMS, PATHOPHYSIOLOGY: MITOCHONDRIAL DYSFUNCTION, OXIDATIVE DAMAGE4
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C01.K. DISEASE MECHANISMS, PATHOPHYSIOLOGY: SYNAPSE PATHOLOGY, NEURAL NETWORKS, PLASTICITY, NEUROGENESIS2
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C01.L. DISEASE MECHANISMS, PATHOPHYSIOLOGY: TRANSCRIPTIONAL & TRANSLATIONAL REGULATION, MICRO RNAS3
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C01.M. DISEASE MECHANISMS, PATHOPHYSIOLOGY: PROTEIN AGGREGATION, MISFOLDING, CHAPERONES2
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C01.N. DISEASE MECHANISMS, PATHOPHYSIOLOGY: METAL IONS2
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C01.O. DISEASE MECHANISMS, PATHOPHYSIOLOGY: MODELING OF DISEASE PROGRESSION6
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C01.P. DISEASE MECHANISMS, PATHOPHYSIOLOGY: OTHER6
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C02.A. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: A-SYNUCLEIN4
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C02.B. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: IMMUNOTHERAPY1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C02.C. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: KINASES, OTHER ENZYMES1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C02.D. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: DOPAMINE, ACETYLCHOLINE, NEUROTRANSMITTERS2
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C02.E. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: CELL TRANSPLANTATION2
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C02.F. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: ANTI-INFLAMMATORY, ANTI-OXIDANT2
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C02.G. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: MICROGLIA2
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C02.I. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: PROTEIN AGGREGATION, MISFOLDING, CHAPERONES1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C02.J. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: GENE THERAPY AND GENE EDITING1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C02.K. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: ASO AND RNAI1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C02.M. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: OTHER13
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C03.A. DRUG DEVELOPMENT, CLINICAL TRIALS: IMMUNOTHERAPY1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C03.B. DRUG DEVELOPMENT, CLINICAL TRIALS: VITAMINS, ANTIOXIDANTS, NEUROPROTECTIVE COMPOUNDS4
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C03.C. DRUG DEVELOPMENT, CLINICAL TRIALS: NEUROTRANSMITTER- AND RECEPTOR BASED MODULATORS1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C03.E. DRUG DEVELOPMENT, CLINICAL TRIALS: ENZYME MODULATORS1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C03.G. DRUG DEVELOPMENT, CLINICAL TRIALS: NON-PHARMACOLOGICAL INTERVENTIONS, NEUROSURGERY1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C04.A. IMAGING, BIOMARKERS, DIAGNOSTICS: STRUCTURAL MRI, MR SPECTROSCOPY4
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C04.C. IMAGING, BIOMARKERS, DIAGNOSTICS: PET1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C04.D. IMAGING, BIOMARKERS, DIAGNOSTICS: SPECT4
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C04.E. IMAGING, BIOMARKERS, DIAGNOSTICS: MULTIMODAL IMAGING3
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C04.F. IMAGING, BIOMARKERS, DIAGNOSTICS: CSF, BLOOD, BODY FLUID BIOMARKERS22
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C04.G. IMAGING, BIOMARKERS, DIAGNOSTICS: EEG, BRAIN MAPPING, MEG3
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C04.H. IMAGING, BIOMARKERS, DIAGNOSTICS: COGNITIVE, PSYCHOMETRIC, BEHAVIORAL AND MOTOR TESTS5
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C04.I. IMAGING, BIOMARKERS, DIAGNOSTICS: OTHER6
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C05.A. GENETICS, EPIDEMIOLOGY: WHOLE GENOME SEQUENCING1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C05.B. GENETICS, EPIDEMIOLOGY: DISEASE-CAUSING MUTATIONS2
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C05.C. GENETICS, EPIDEMIOLOGY: GWAS, GENETIC ASSOCIATIONS, SUSCEPTIBILITY & PROTECTIVE GENES3
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C05.E. GENETICS, EPIDEMIOLOGY: OTHER3
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C06.A. CELL, MOLECULAR AND SYSTEMS BIOLOGY: A-SYNUCLEIN1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C06.B. CELL, MOLECULAR AND SYSTEMS BIOLOGY: LRKK2, PARKIN, PINK1, DJ-1 AND OTHER PD REALTED GENES2
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C06.D. CELL, MOLECULAR AND SYSTEMS BIOLOGY: METABOLOMICS, TRANSCRIPTOMICS, LIPIDOMICS, PROTEOMICS1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C06.E. CELL, MOLECULAR AND SYSTEMS BIOLOGY: EPIGENETICS, HISTONE MODIFICATION, DNA METHYLATION1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C06.F. CELL, MOLECULAR AND SYSTEMS BIOLOGY: OTHER1
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C07.A. ANIMAL MODELS: TRANSGENIC RODENTS4
POSTER SHIFT 01 (MARCH 6-7): THEME C: Α-SYNUCLEINOPATHIES / C07.C. ANIMAL MODELS: NON-MAMMALIAN MODELS ,OTHER2
POSTER SHIFT 01 (MARCH 6-7): THEME D: TDP43, TMEM106B AND C9ORF72-RELATED DISEASES / D01. DISEASE MECHANISMS, PATHOPHYSIOLOGY5
POSTER SHIFT 01 (MARCH 6-7): THEME D: TDP43, TMEM106B AND C9ORF72-RELATED DISEASES / D02. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT6
POSTER SHIFT 01 (MARCH 6-7): THEME D: TDP43, TMEM106B AND C9ORF72-RELATED DISEASES / D03. IMAGING, BIOMARKERS, DIAGNOSTICS1
POSTER SHIFT 01 (MARCH 6-7): THEME D: TDP43, TMEM106B AND C9ORF72-RELATED DISEASES / D04. GENETICS, EPIDEMIOLOGY1
POSTER SHIFT 01 (MARCH 6-7): THEME D: TDP43, TMEM106B AND C9ORF72-RELATED DISEASES / D05. CELL, MOLECULAR AND SYSTEMS BIOLOGY4
POSTER SHIFT 01 (MARCH 6-7): THEME E : VASCULAR DISEASES / E01. DISEASE MECHANISMS, PATHOPHYSIOLOGY3
POSTER SHIFT 01 (MARCH 6-7): THEME E : VASCULAR DISEASES / E02. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT3
POSTER SHIFT 01 (MARCH 6-7): THEME E : VASCULAR DISEASES / E03. IMAGING, BIOMARKERS, DIAGNOSTICS1
POSTER SHIFT 01 (MARCH 6-7): THEME E : VASCULAR DISEASES / E04. GENETICS, EPIDEMIOLOGY1
POSTER SHIFT 01 (MARCH 6-7): THEME E : VASCULAR DISEASES / E05. CELL, MOLECULAR AND SYSTEMS BIOLOGY2
POSTER SHIFT 01 (MARCH 6-7): THEME E : VASCULAR DISEASES / E06. ANIMAL MODELS1
POSTER SHIFT 01 (MARCH 6-7): THEME F: PRION DISEASES / F01. DISEASE MECHANISMS, PATHOPHYSIOLOGY2
POSTER SHIFT 01 (MARCH 6-7): THEME F: PRION DISEASES / F03. IMAGING, BIOMARKERS, DIAGNOSTICS1
POSTER SHIFT 01 (MARCH 6-7): THEME G: HUNTINGTON'S AND OTHER NEURODEGENERATIVE DISEASES / G01. DISEASE MECHANISMS, PATHOPHYSIOLOGY2
POSTER SHIFT 01 (MARCH 6-7): THEME G: HUNTINGTON'S AND OTHER NEURODEGENERATIVE DISEASES / G02. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT6
POSTER SHIFT 01 (MARCH 6-7): THEME G: HUNTINGTON'S AND OTHER NEURODEGENERATIVE DISEASES / G04. IMAGING, BIOMARKERS, DIAGNOSTICS2
POSTER SHIFT 01 (MARCH 6-7): THEME G: HUNTINGTON'S AND OTHER NEURODEGENERATIVE DISEASES / G05. GENETICS, EPIDEMIOLOGY1
POSTER SHIFT 01 (MARCH 6-7): THEME G: HUNTINGTON'S AND OTHER NEURODEGENERATIVE DISEASES / G06. CELL, MOLECULAR AND SYSTEMS BIOLOGY5
POSTER SHIFT 01 (MARCH 6-7): THEME G: HUNTINGTON'S AND OTHER NEURODEGENERATIVE DISEASES / G07. ANIMAL MODELS1
POSTER SHIFT 01 (MARCH 6-7): THEME H: DEMYELINATING DISEASES / H01. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT3
POSTER SHIFT 01 (MARCH 6-7): THEME H: DEMYELINATING DISEASES / H02. IMAGING, BIOMARKERS, DIAGNOSTICS2
POSTER SHIFT 01 (MARCH 6-7): THEME I: LYSOSOMAL STORAGE DISEASES / I01. DISEASE MECHANISMS, PATHOPHYSIOLOGY1
POSTER SHIFT 01 (MARCH 6-7): THEME I: LYSOSOMAL STORAGE DISEASES / I02. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT2
POSTER SHIFT 01 (MARCH 6-7): THEME J: PSYCHIATRIC SYMPTOMS IN NEURODEGENERATIVE DISEASES / J01. DISEASE MECHANISMS, PATHOPHYSIOLOGY1
POSTER SHIFT 01 (MARCH 6-7): THEME J: PSYCHIATRIC SYMPTOMS IN NEURODEGENERATIVE DISEASES / J02. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT4
POSTER SHIFT 01 (MARCH 6-7): THEME J: PSYCHIATRIC SYMPTOMS IN NEURODEGENERATIVE DISEASES / J03. DRUG DEVELOPMENT, CLINICAL TRIALS3
POSTER SHIFT 01 (MARCH 6-7): THEME J: PSYCHIATRIC SYMPTOMS IN NEURODEGENERATIVE DISEASES / J04. IMAGING, BIOMARKERS, DIAGNOSTICS1
POSTER SHIFT 01 (MARCH 6-7): THEME J: PSYCHIATRIC SYMPTOMS IN NEURODEGENERATIVE DISEASES / J05. GENETICS, EPIDEMIOLOGY1
POSTER SHIFT 01 (MARCH 6-7): THEME J: PSYCHIATRIC SYMPTOMS IN NEURODEGENERATIVE DISEASES / J07. ANIMAL MODELS2
POSTER SHIFT 01 (MARCH 6-7): THEME K: PATIENT CARE AND SUPPORT / K01.A. DEMENTIA AND COGNITIVE DYFUNCTION: CAREGIVER SUPPORT8
POSTER SHIFT 01 (MARCH 6-7): THEME K: PATIENT CARE AND SUPPORT / K01.B. DEMENTIA AND COGNITIVE DYFUNCTION: MOBILE APPLICATIONS, SOCIAL NETWORKS2
POSTER SHIFT 01 (MARCH 6-7): THEME K: PATIENT CARE AND SUPPORT / K01.C. DEMENTIA AND COGNITIVE DYFUNCTION: COGNITIVE TRAINING6
POSTER SHIFT 01 (MARCH 6-7): THEME K: PATIENT CARE AND SUPPORT / K01.D. DEMENTIA AND COGNITIVE DYFUNCTION: SUPPORT DEVICES & MONITORING3
POSTER SHIFT 01 (MARCH 6-7): THEME K: PATIENT CARE AND SUPPORT / K01.E. DEMENTIA AND COGNITIVE DYFUNCTION: QUALITY OF LIFE2
POSTER SHIFT 01 (MARCH 6-7): THEME K: PATIENT CARE AND SUPPORT / K01.F. DEMENTIA AND COGNITIVE DYFUNCTION: BEHAVIORAL & PSYCHIATRIC SYMPTOMS2
POSTER SHIFT 01 (MARCH 6-7): THEME K: PATIENT CARE AND SUPPORT / K01.G. DEMENTIA AND COGNITIVE DYFUNCTION: OTHER5
POSTER SHIFT 01 (MARCH 6-7): THEME K: PATIENT CARE AND SUPPORT / K02.B. MOVEMENT DISORDERS: MOTOR COORDINATION & EXERCISE2
POSTER SHIFT 01 (MARCH 6-7): THEME K: PATIENT CARE AND SUPPORT / K02.C. MOVEMENT DISORDERS: SUPPORT DEVICES & MONITORING1
POSTER SHIFT 01 (MARCH 6-7): THEME K: PATIENT CARE AND SUPPORT / K02.D. MOVEMENT DISORDERS: QUALITY OF LIFE5
POSTER SHIFT 01 (MARCH 6-7): THEME K: PATIENT CARE AND SUPPORT / K02.E. MOVEMENT DISORDERS: BEHAVIORAL & PSYCHIATRIC SYMPTOMS1
POSTER SHIFT 01 (MARCH 6-7): THEME K: PATIENT CARE AND SUPPORT / K02.F. MOVEMENT DISORDERS: OTHER1
POSTER SHIFT 01 (MARCH 6-7): THEME L: COVID-19: IMPACT ON BRAIN NEURODEGENERATIVE DISEASES / L01C. NEUROLOGICAL MANIFESTATIONS OF COVID-192
POSTER SHIFT 01 (MARCH 6-7): THEME L: COVID-19: IMPACT ON BRAIN NEURODEGENERATIVE DISEASES / L01E. CNS INVASION OF SARS-COV21
POSTER SHIFT 01 (MARCH 6-7): THEME L: COVID-19: IMPACT ON BRAIN NEURODEGENERATIVE DISEASES / L01F. EPIDEMIOLOGY OF COVID-19 IN PATIENTS WITH NEURODEGENERATIVE DISEASES3
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A01.A. DISEASE MECHANISMS, PATHOPHYSIOLOGY: ABETA AGGREGATION, PROTEIN MISFOLDING13
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A01.C. DISEASE MECHANISMS, PATHOPHYSIOLOGY: INFLAMMATION9
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A01.D. DISEASE MECHANISMS, PATHOPHYSIOLOGY: SYNAPTIC PLASTCITY & SYNAPSE PATHOLOGY8
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A01.E. DISEASE MECHANISMS, PATHOPHYSIOLOGY: CELLULAR SIGNALLING, KINASES, PHOSPHATASES, CALCIUM4
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A01.F. DISEASE MECHANISMS, PATHOPHYSIOLOGY: LYSOSOMES, UBIQUITIN, PROTEASOME, ER STRESS, CHAPERONES1
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A01.G. DISEASE MECHANISMS, PATHOPHYSIOLOGY: MITOCHONDRIAL DYSFUNCTION, OXIDATIVE DAMAGE5
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A01.H. DISEASE MECHANISMS, PATHOPHYSIOLOGY: LIPIDS, LIPOPROTEINS AND MEMBRANE TRAFFICKING3
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A01.I. DISEASE MECHANISMS, PATHOPHYSIOLOGY: MICROGLIA10
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A01.J. DISEASE MECHANISMS, PATHOPHYSIOLOGY: ASTROGLIA3
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A01.K. DISEASE MECHANISMS, PATHOPHYSIOLOGY: NEUROGENESIS1
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A01.L. DISEASE MECHANISMS, PATHOPHYSIOLOGY: VASCULATURE, MICROBLEEDS, HYPERTENSION, ANGIOGENESIS5
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A01.M. DISEASE MECHANISMS, PATHOPHYSIOLOGY: BLOOD-BRAIN BARRIER1
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A01.N. DISEASE MECHANISMS, PATHOPHYSIOLOGY: METABOLISM, INSULIN3
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A01.P. DISEASE MECHANISMS, PATHOPHYSIOLOGY: TRANSCRIPTIONAL & TRANSLATIONAL REGULATION, MICRO RNAS5
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A01.Q. DISEASE MECHANISMS, PATHOPHYSIOLOGY: AUTOPHAGY, APOPTOSIS, CELL DEATH3
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A01.R. DISEASE MECHANISMS, PATHOPHYSIOLOGY: AGING3
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A01.S. DISEASE MECHANISMS, PATHOPHYSIOLOGY: MICROBIOME2
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A02.A. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: ABETA, TRUNCATED & PGLU-ABETA6
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A02.B. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: IMMUNOTHERAPY1
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A02.C. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: SECRETASES, PROTEASES6
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A02.D. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: KINASES, OTHER ENZYMES2
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A02.E. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: NEUROTRANSMITTERS & RECEPTOR-BASED4
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A02.F. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: APOE & LIPOPROTEIN-BASED2
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A02.G. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: ANTI-INFLAMMATORY3
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A02.H. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: ANTI-OXIDANTS2
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A02.I. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: NEUROTROPHIC, SYNAPTIC PLASTICITY, REPAIR, REGENERATIVE MEDICINE4
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A02.J. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: PROTEIN AGGREGATION, MISFOLDING, CHAPERONES1
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A02.M. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: MICROGLIA5
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A02.N. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: ASTROGLIA1
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A02.Q. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: OTHER13
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A03.A. DRUG DEVELOPMENT, CLINICAL TRIALS: IMMUNOTHERAPY2
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A03.B. DRUG DEVELOPMENT, CLINICAL TRIALS: AMYLOID CLEARANCE3
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A03.E. DRUG DEVELOPMENT, CLINICAL TRIALS: NEUROPROTECTIVE & MITOCHONDRIAL COMPOUNDS1
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A03.H. DRUG DEVELOPMENT, CLINICAL TRIALS: MEDICINAL CHEMISTRY APPROACHES, DRUG REPURPOSING1
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A03.I. DRUG DEVELOPMENT, CLINICAL TRIALS: PERSONALIZED MEDICINES, SEX /RACE, AI, AND COMBINATION THERAPY3
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A03.J. DRUG DEVELOPMENT, CLINICAL TRIALS:NEW CLINICAL TRIAL DESIGNS; SIMULATION OF PROGRESS-DIGITAL TWINS2
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A03.L. DRUG DEVELOPMENT, CLINICAL TRIALS: REGULATORY ASPECTS, OTHER2
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A04.A. IMAGING, BIOMARKERS, DIAGNOSTICS: STRUCTURAL MRI, MR SPECTROSCOPY8
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A04.C. IMAGING, BIOMARKERS, DIAGNOSTICS: PET - THEME A: Β-AMYLOID DISEASES / AMYLOID2
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A04.D. IMAGING, BIOMARKERS, DIAGNOSTICS: PET - THEME G: HUNTINGTON'S AND OTHER NEURODEGENERATIVE DISEASES / GLUCOSE2
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A04.E. IMAGING, BIOMARKERS, DIAGNOSTICS: PET - OTHER2
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A04.F. IMAGING, BIOMARKERS, DIAGNOSTICS: MULTIMODAL IMAGING9
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A04.G. IMAGING, BIOMARKERS, DIAGNOSTICS: CSF, BLOOD, BODY FLUID BIOMARKERS43
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A04.H. IMAGING, BIOMARKERS, DIAGNOSTICS: EEG, BRAIN MAPPING, MEG2
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A04.I. IMAGING, BIOMARKERS, DIAGNOSTICS: COGNITIVE, PSYCHOMETRIC & BEHAVIORAL TESTS, DIGITAL ENDPOINTS, REMOTE TESTING8
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A04.J. IMAGING, BIOMARKERS, DIAGNOSTICS: OTHER6
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A05.B. GENETICS, EPIDEMIOLOGY: DISEASE-CAUSING MUTATIONS4
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A05.C. GENETICS, EPIDEMIOLOGY: GWAS, GENETIC ASSOCIATIONS, SUSCEPTIBILITY & PROTECTIVE GENES9
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A05.D. GENETICS, EPIDEMIOLOGY: AGING3
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A05.E. GENETICS, EPIDEMIOLOGY: ENVIRONMENTAL RISK FACTORS4
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A05.F. GENETICS, EPIDEMIOLOGY: METABOLIC AND CARDIOVASCULAR1
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A05.G. GENETICS, EPIDEMIOLOGY: INFECTIOUS AND INFLAMMATION3
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A05.H. GENETICS, EPIDEMIOLOGY: OTHER3
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A06.A. CELL, MOLECULAR AND SYSTEMS BIOLOGY: APP, APLP, ABETA4
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A06.B. CELL, MOLECULAR AND SYSTEMS BIOLOGY: APOE6
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A06.D. CELL, MOLECULAR AND SYSTEMS BIOLOGY: NETWORK BIOLOGY, CONNECTOME, PROTEIN-PROTEIN INTERATIONS2
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A06.E. CELL, MOLECULAR AND SYSTEMS BIOLOGY: METABOLOMICS, TRANSCRIPTOMICS, LIPIDOMICS, PROTEOMICS12
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A06.F. CELL, MOLECULAR AND SYSTEMS BIOLOGY: EPIGENETICS, HISTONE MODIFICATION, DNA METHYLATION5
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A06.G. CELL, MOLECULAR AND SYSTEMS BIOLOGY: OTHER5
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A07.A. ANIMAL MODELS: TRANSGENIC RODENTS4
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A07.B. ANIMAL MODELS: PRIMATES, NATURALLY OCCURING MODELS AND BRAIN ORGANOIDS2
POSTER SHIFT 02 (MARCH 8-9): THEME A: Β-AMYLOID DISEASES / A07.C. ANIMAL MODELS: NON-MAMALIAN MODELS, OTHER1
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B01.A. DISEASE MECHANISMS, PATHOPHYSIOLOGY: TAU AGGREGATION, PHOPHORYLATION, ACETYLATION & MODIFICATIONS13
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B01.B. DISEASE MECHANISMS, PATHOPHYSIOLOGY: CELL TO CELL TRANSMISSION, SPREADING OF PATHOLOGY, PRION-LIKE9
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B01.C. DISEASE MECHANISMS, PATHOPHYSIOLOGY: INFLAMMATION1
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B01.D. DISEASE MECHANISMS, PATHOPHYSIOLOGY: SYNAPSE PATHOLOGY1
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B01.E. DISEASE MECHANISMS, PATHOPHYSIOLOGY: CELLULAR SIGNALLING, KINASES, PHOSPHATASES, CALCIUM2
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B01.F. DISEASE MECHANISMS, PATHOPHYSIOLOGY: LYSOSOMES, UBIQUITIN, PROTEASOME, ER STRESS2
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B01.G. DISEASE MECHANISMS, PATHOPHYSIOLOGY: MITOCHONDRIAL DYSFUNCTION, OXIDATIVE DAMAGE5
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B01.H.DISEASE MECHANISMS, PATHOPHYSIOLOGY: MICROGLIA1
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B01.L. DISEASE MECHANISMS, PATHOPHYSIOLOGY: NEURAL NETWORKS & PLASTICITY3
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B01.O. DISEASE MECHANISMS, PATHOPHYSIOLOGY: AGING3
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B01.P. DISEASE MECHANISMS, PATHOPHYSIOLOGY: OTHER3
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B02.A. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: TAU, PHOSPHORYLATION, TRUNCATION2
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B02.B. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: IMMUNOTHERAPY1
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B02.C. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: KINASES, PHOSPHATASES, OTHER ENZYMES1
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B02.D. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: NEUROTRANSMITTERS & RECEPTOR-BASED1
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B02.F. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: PROTEIN AGGREGATION, NFT, MISFOLDING, CHAPERONES2
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B02.G. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: GENE AND RNAI THERAPY1
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B02.I. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: OTHER1
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B03.A. DRUG DEVELOPMENT, CLINICAL TRIALS: IMMUNOTHERAPY1
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B03.C. DRUG DEVELOPMENT, CLINICAL TRIALS: AGGREGATION INHIBITORS1
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B03.E. DRUG DEVELOPMENT, CLINICAL TRIALS: COMBINATION THERAPY, SEX/RACE, PERSONALIZED MEDICINES, AI, OTHER1
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B04.A. IMAGING, BIOMARKERS, DIAGNOSTICS: STRUCTURAL MRI, MR SPECTROSCOPY2
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B04.B. IMAGING, BIOMARKERS, DIAGNOSTICS: PET - TAU2
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B04.E. IMAGING, BIOMARKERS, DIAGNOSTICS: CSF, BLOOD, BODY FLUID BIOMARKERS6
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B04.G. IMAGING, BIOMARKERS, DIAGNOSTICS: COGNITIVE, PSYCHOMETRIC & BEHAVIORAL TESTS, DIGITAL ENDPOINTS, REMOTE TESTING1
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B04.H. IMAGING, BIOMARKERS, DIAGNOSTICS: OTHER4
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B06.A. CELL, MOLECULAR AND SYSTEMS BIOLOGY: TAU, TAU ISOFORMS2
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B06.D. CELL, MOLECULAR AND SYSTEMS BIOLOGY: METABOLOMICS, TRANSCRIPTOMICS, LIPIDOMICS, PROTEOMICS3
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B07.A. ANIMAL MODELS: TRANSGENIC RODENTS1
POSTER SHIFT 02 (MARCH 8-9): THEME B: TAUPATHIES / B07.B. ANIMAL MODELS: PRIMATES, NATURALLY OCCURING MODELS AND BRAIN ORGANOIDS1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C01.A. DISEASE MECHANISMS, PATHOPHYSIOLOGY: A-SYNUCLEIN AGGREGATION6
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C01.B. DISEASE MECHANISMS, PATHOPHYSIOLOGY: LRKK2, PARKIN, PINK1, DJ-19
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C01.C. DISEASE MECHANISMS, PATHOPHYSIOLOGY: CELL TO CELL TRANSMISSION, SPREADING OF PATHOLOGY, PRION-LIKE4
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C01.D. DISEASE MECHANISMS, PATHOPHYSIOLOGY: AUTOPHAGY, LYSOSOMES, UBIQUITIN, PROTEASOME3
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C01.E. DISEASE MECHANISMS, PATHOPHYSIOLOGY: LIPIDS, LIPOPROTEINS AND MEMBRANE TRAFFICKING1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C01.F. DISEASE MECHANISMS, PATHOPHYSIOLOGY: INFLAMMATION8
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C01.G. DISEASE MECHANISMS, PATHOPHYSIOLOGY: MICROGLIA1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C01.H. DISEASE MECHANISMS, PATHOPHYSIOLOGY: ASTROGLIA1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C01.I. DISEASE MECHANISMS, PATHOPHYSIOLOGY: CELLULAR SIGNALLING, KINASES, PHOSPHATASES, CALCIUM1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C01.J. DISEASE MECHANISMS, PATHOPHYSIOLOGY: MITOCHONDRIAL DYSFUNCTION, OXIDATIVE DAMAGE4
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C01.K. DISEASE MECHANISMS, PATHOPHYSIOLOGY: SYNAPSE PATHOLOGY, NEURAL NETWORKS, PLASTICITY, NEUROGENESIS1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C01.L. DISEASE MECHANISMS, PATHOPHYSIOLOGY: TRANSCRIPTIONAL & TRANSLATIONAL REGULATION, MICRO RNAS1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C01.M. DISEASE MECHANISMS, PATHOPHYSIOLOGY: PROTEIN AGGREGATION, MISFOLDING, CHAPERONES3
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C01.N. DISEASE MECHANISMS, PATHOPHYSIOLOGY: METAL IONS2
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C01.O. DISEASE MECHANISMS, PATHOPHYSIOLOGY: MODELING OF DISEASE PROGRESSION5
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C01.P. DISEASE MECHANISMS, PATHOPHYSIOLOGY: OTHER6
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C02.A. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: A-SYNUCLEIN11
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C02.B. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: IMMUNOTHERAPY2
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C02.F. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: ANTI-INFLAMMATORY, ANTI-OXIDANT7
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C02.G. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: MICROGLIA1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C02.I. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: PROTEIN AGGREGATION, MISFOLDING, CHAPERONES2
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C02.J. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: GENE THERAPY AND GENE EDITING1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C02.K. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: ASO AND RNAI1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C02.M. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: OTHER10
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C03.B. DRUG DEVELOPMENT, CLINICAL TRIALS: VITAMINS, ANTIOXIDANTS, NEUROPROTECTIVE COMPOUNDS4
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C03.C. DRUG DEVELOPMENT, CLINICAL TRIALS: NEUROTRANSMITTER- AND RECEPTOR BASED MODULATORS1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C03.F. DRUG DEVELOPMENT, CLINICAL TRIALS: DRUG DELIVERY SYSTEMS1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C03.G. DRUG DEVELOPMENT, CLINICAL TRIALS: NON-PHARMACOLOGICAL INTERVENTIONS, NEUROSURGERY1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C04.A. IMAGING, BIOMARKERS, DIAGNOSTICS: STRUCTURAL MRI, MR SPECTROSCOPY2
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C04.C. IMAGING, BIOMARKERS, DIAGNOSTICS: PET8
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C04.E. IMAGING, BIOMARKERS, DIAGNOSTICS: MULTIMODAL IMAGING3
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C04.F. IMAGING, BIOMARKERS, DIAGNOSTICS: CSF, BLOOD, BODY FLUID BIOMARKERS17
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C04.G. IMAGING, BIOMARKERS, DIAGNOSTICS: EEG, BRAIN MAPPING, MEG1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C04.H. IMAGING, BIOMARKERS, DIAGNOSTICS: COGNITIVE, PSYCHOMETRIC, BEHAVIORAL AND MOTOR TESTS2
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C04.I. IMAGING, BIOMARKERS, DIAGNOSTICS: OTHER4
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C05.A. GENETICS, EPIDEMIOLOGY: WHOLE GENOME SEQUENCING1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C05.B. GENETICS, EPIDEMIOLOGY: DISEASE-CAUSING MUTATIONS1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C05.C. GENETICS, EPIDEMIOLOGY: GWAS, GENETIC ASSOCIATIONS, SUSCEPTIBILITY & PROTECTIVE GENES2
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C05.E. GENETICS, EPIDEMIOLOGY: OTHER1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C06.A. CELL, MOLECULAR AND SYSTEMS BIOLOGY: A-SYNUCLEIN2
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C06.B. CELL, MOLECULAR AND SYSTEMS BIOLOGY: LRKK2, PARKIN, PINK1, DJ-1 AND OTHER PD REALTED GENES1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C06.C. CELL, MOLECULAR AND SYSTEMS BIOLOGY: NETWORK BIOLOGY, CONNECTOME, PROTEIN-PROTEIN INTERATIONS1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C06.D. CELL, MOLECULAR AND SYSTEMS BIOLOGY: METABOLOMICS, TRANSCRIPTOMICS, LIPIDOMICS, PROTEOMICS3
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C06.E. CELL, MOLECULAR AND SYSTEMS BIOLOGY: EPIGENETICS, HISTONE MODIFICATION, DNA METHYLATION1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C06.F. CELL, MOLECULAR AND SYSTEMS BIOLOGY: OTHER1
POSTER SHIFT 02 (MARCH 8-9): THEME C: Α-SYNUCLEINOPATHIES / C07.A. ANIMAL MODELS: TRANSGENIC RODENTS1
POSTER SHIFT 02 (MARCH 8-9): THEME D: TDP43, TMEM106B AND C9ORF72-RELATED DISEASES / D01. DISEASE MECHANISMS, PATHOPHYSIOLOGY10
POSTER SHIFT 02 (MARCH 8-9): THEME D: TDP43, TMEM106B AND C9ORF72-RELATED DISEASES / D02. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT1
POSTER SHIFT 02 (MARCH 8-9): THEME D: TDP43, TMEM106B AND C9ORF72-RELATED DISEASES / D03. IMAGING, BIOMARKERS, DIAGNOSTICS4
POSTER SHIFT 02 (MARCH 8-9): THEME D: TDP43, TMEM106B AND C9ORF72-RELATED DISEASES / D04. GENETICS, EPIDEMIOLOGY4
POSTER SHIFT 02 (MARCH 8-9): THEME D: TDP43, TMEM106B AND C9ORF72-RELATED DISEASES / D05. CELL, MOLECULAR AND SYSTEMS BIOLOGY3
POSTER SHIFT 02 (MARCH 8-9): THEME D: TDP43, TMEM106B AND C9ORF72-RELATED DISEASES / D06. ANIMAL MODELS2
POSTER SHIFT 02 (MARCH 8-9): THEME E : VASCULAR DISEASES / E01. DISEASE MECHANISMS, PATHOPHYSIOLOGY5
POSTER SHIFT 02 (MARCH 8-9): THEME E : VASCULAR DISEASES / E02. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT1
POSTER SHIFT 02 (MARCH 8-9): THEME E : VASCULAR DISEASES / E03. IMAGING, BIOMARKERS, DIAGNOSTICS6
POSTER SHIFT 02 (MARCH 8-9): THEME E : VASCULAR DISEASES / E04. GENETICS, EPIDEMIOLOGY1
POSTER SHIFT 02 (MARCH 8-9): THEME E : VASCULAR DISEASES / E06. ANIMAL MODELS1
POSTER SHIFT 02 (MARCH 8-9): THEME F: PRION DISEASES / F01. DISEASE MECHANISMS, PATHOPHYSIOLOGY1
POSTER SHIFT 02 (MARCH 8-9): THEME G: HUNTINGTON'S AND OTHER NEURODEGENERATIVE DISEASES / G01. DISEASE MECHANISMS, PATHOPHYSIOLOGY5
POSTER SHIFT 02 (MARCH 8-9): THEME G: HUNTINGTON'S AND OTHER NEURODEGENERATIVE DISEASES / G02. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT7
POSTER SHIFT 02 (MARCH 8-9): THEME G: HUNTINGTON'S AND OTHER NEURODEGENERATIVE DISEASES / G04. IMAGING, BIOMARKERS, DIAGNOSTICS4
POSTER SHIFT 02 (MARCH 8-9): THEME G: HUNTINGTON'S AND OTHER NEURODEGENERATIVE DISEASES / G05. GENETICS, EPIDEMIOLOGY4
POSTER SHIFT 02 (MARCH 8-9): THEME G: HUNTINGTON'S AND OTHER NEURODEGENERATIVE DISEASES / G06. CELL, MOLECULAR AND SYSTEMS BIOLOGY2
POSTER SHIFT 02 (MARCH 8-9): THEME G: HUNTINGTON'S AND OTHER NEURODEGENERATIVE DISEASES / G07. ANIMAL MODELS1
POSTER SHIFT 02 (MARCH 8-9): THEME H: DEMYELINATING DISEASES / H01. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT3
POSTER SHIFT 02 (MARCH 8-9): THEME H: DEMYELINATING DISEASES / H02. IMAGING, BIOMARKERS, DIAGNOSTICS1
POSTER SHIFT 02 (MARCH 8-9): THEME H: DEMYELINATING DISEASES / H03. ANIMAL MODELS2
POSTER SHIFT 02 (MARCH 8-9): THEME I: LYSOSOMAL STORAGE DISEASES / I01. DISEASE MECHANISMS, PATHOPHYSIOLOGY1
POSTER SHIFT 02 (MARCH 8-9): THEME I: LYSOSOMAL STORAGE DISEASES / I02. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT1
POSTER SHIFT 02 (MARCH 8-9): THEME J: PSYCHIATRIC SYMPTOMS IN NEURODEGENERATIVE DISEASES / J01. DISEASE MECHANISMS, PATHOPHYSIOLOGY3
POSTER SHIFT 02 (MARCH 8-9): THEME J: PSYCHIATRIC SYMPTOMS IN NEURODEGENERATIVE DISEASES / J02. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT3
POSTER SHIFT 02 (MARCH 8-9): THEME J: PSYCHIATRIC SYMPTOMS IN NEURODEGENERATIVE DISEASES / J04. IMAGING, BIOMARKERS, DIAGNOSTICS6
POSTER SHIFT 02 (MARCH 8-9): THEME J: PSYCHIATRIC SYMPTOMS IN NEURODEGENERATIVE DISEASES / J05. GENETICS, EPIDEMIOLOGY1
POSTER SHIFT 02 (MARCH 8-9): THEME J: PSYCHIATRIC SYMPTOMS IN NEURODEGENERATIVE DISEASES / J06. CELL, MOLECULAR AND SYSTEMS BIOLOGY1
POSTER SHIFT 02 (MARCH 8-9): THEME J: PSYCHIATRIC SYMPTOMS IN NEURODEGENERATIVE DISEASES / J07. ANIMAL MODELS2
POSTER SHIFT 02 (MARCH 8-9): THEME K: PATIENT CARE AND SUPPORT / K01.A. DEMENTIA AND COGNITIVE DYFUNCTION: CAREGIVER SUPPORT3
POSTER SHIFT 02 (MARCH 8-9): THEME K: PATIENT CARE AND SUPPORT / K01.B. DEMENTIA AND COGNITIVE DYFUNCTION: MOBILE APPLICATIONS, SOCIAL NETWORKS6
POSTER SHIFT 02 (MARCH 8-9): THEME K: PATIENT CARE AND SUPPORT / K01.C. DEMENTIA AND COGNITIVE DYFUNCTION: COGNITIVE TRAINING1
POSTER SHIFT 02 (MARCH 8-9): THEME K: PATIENT CARE AND SUPPORT / K01.D. DEMENTIA AND COGNITIVE DYFUNCTION: SUPPORT DEVICES & MONITORING2
POSTER SHIFT 02 (MARCH 8-9): THEME K: PATIENT CARE AND SUPPORT / K01.E. DEMENTIA AND COGNITIVE DYFUNCTION: QUALITY OF LIFE6
POSTER SHIFT 02 (MARCH 8-9): THEME K: PATIENT CARE AND SUPPORT / K01.F. DEMENTIA AND COGNITIVE DYFUNCTION: BEHAVIORAL & PSYCHIATRIC SYMPTOMS6
POSTER SHIFT 02 (MARCH 8-9): THEME K: PATIENT CARE AND SUPPORT / K01.G. DEMENTIA AND COGNITIVE DYFUNCTION: OTHER5
POSTER SHIFT 02 (MARCH 8-9): THEME K: PATIENT CARE AND SUPPORT / K02.B. MOVEMENT DISORDERS: MOTOR COORDINATION & EXERCISE1
POSTER SHIFT 02 (MARCH 8-9): THEME K: PATIENT CARE AND SUPPORT / K02.C. MOVEMENT DISORDERS: SUPPORT DEVICES & MONITORING2
POSTER SHIFT 02 (MARCH 8-9): THEME K: PATIENT CARE AND SUPPORT / K02.D. MOVEMENT DISORDERS: QUALITY OF LIFE2
POSTER SHIFT 02 (MARCH 8-9): THEME K: PATIENT CARE AND SUPPORT / K02.E. MOVEMENT DISORDERS: BEHAVIORAL & PSYCHIATRIC SYMPTOMS1
POSTER SHIFT 02 (MARCH 8-9): THEME K: PATIENT CARE AND SUPPORT / K02.F. MOVEMENT DISORDERS: OTHER3
POSTER SHIFT 02 (MARCH 8-9): THEME L: COVID-19: IMPACT ON BRAIN NEURODEGENERATIVE DISEASES / L01A. NEUROPATHOLOGY OF COVID-191
POSTER SHIFT 02 (MARCH 8-9): THEME L: COVID-19: IMPACT ON BRAIN NEURODEGENERATIVE DISEASES / L01C. NEUROLOGICAL MANIFESTATIONS OF COVID-193
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A01.A. DISEASE MECHANISMS, PATHOPHYSIOLOGY: ABETA AGGREGATION, PROTEIN MISFOLDING1
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A01.C. DISEASE MECHANISMS, PATHOPHYSIOLOGY: INFLAMMATION3
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A01.D. DISEASE MECHANISMS, PATHOPHYSIOLOGY: SYNAPTIC PLASTCITY & SYNAPSE PATHOLOGY3
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A01.I. DISEASE MECHANISMS, PATHOPHYSIOLOGY: MICROGLIA2
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A01.J. DISEASE MECHANISMS, PATHOPHYSIOLOGY: ASTROGLIA1
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A01.R. DISEASE MECHANISMS, PATHOPHYSIOLOGY: AGING3
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A02.G. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: ANTI-INFLAMMATORY2
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A02.J. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: PROTEIN AGGREGATION, MISFOLDING, CHAPERONES1
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A02.Q. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: OTHER2
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A03.A. DRUG DEVELOPMENT, CLINICAL TRIALS: IMMUNOTHERAPY1
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A03.E. DRUG DEVELOPMENT, CLINICAL TRIALS: NEUROPROTECTIVE & MITOCHONDRIAL COMPOUNDS2
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A03.H. DRUG DEVELOPMENT, CLINICAL TRIALS: MEDICINAL CHEMISTRY APPROACHES, DRUG REPURPOSING3
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A03.I. DRUG DEVELOPMENT, CLINICAL TRIALS: PERSONALIZED MEDICINES, SEX /RACE, AI, AND COMBINATION THERAPY1
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A04.A. IMAGING, BIOMARKERS, DIAGNOSTICS: STRUCTURAL MRI, MR SPECTROSCOPY1
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A04.F. IMAGING, BIOMARKERS, DIAGNOSTICS: MULTIMODAL IMAGING2
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A04.G. IMAGING, BIOMARKERS, DIAGNOSTICS: CSF, BLOOD, BODY FLUID BIOMARKERS8
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A04.H. IMAGING, BIOMARKERS, DIAGNOSTICS: EEG, BRAIN MAPPING, MEG1
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A04.I. IMAGING, BIOMARKERS, DIAGNOSTICS: COGNITIVE, PSYCHOMETRIC & BEHAVIORAL TESTS, DIGITAL ENDPOINTS, REMOTE TESTING1
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A05.C. GENETICS, EPIDEMIOLOGY: GWAS, GENETIC ASSOCIATIONS, SUSCEPTIBILITY & PROTECTIVE GENES1
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A05.H. GENETICS, EPIDEMIOLOGY: OTHER1
SHIFT 01 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A06.E. CELL, MOLECULAR AND SYSTEMS BIOLOGY: METABOLOMICS, TRANSCRIPTOMICS, LIPIDOMICS, PROTEOMICS1
SHIFT 01 - VIRTUAL ORAL: THEME B: TAUPATHIES / B01.A. DISEASE MECHANISMS, PATHOPHYSIOLOGY: TAU AGGREGATION, PHOPHORYLATION, ACETYLATION & MODIFICATIONS1
SHIFT 01 - VIRTUAL ORAL: THEME B: TAUPATHIES / B01.B. DISEASE MECHANISMS, PATHOPHYSIOLOGY: CELL TO CELL TRANSMISSION, SPREADING OF PATHOLOGY, PRION-LIKE1
SHIFT 01 - VIRTUAL ORAL: THEME B: TAUPATHIES / B01.O. DISEASE MECHANISMS, PATHOPHYSIOLOGY: AGING1
SHIFT 01 - VIRTUAL ORAL: THEME B: TAUPATHIES / B01.P. DISEASE MECHANISMS, PATHOPHYSIOLOGY: OTHER1
SHIFT 01 - VIRTUAL ORAL: THEME B: TAUPATHIES / B02.I. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: OTHER1
SHIFT 01 - VIRTUAL ORAL: THEME B: TAUPATHIES / B04.E. IMAGING, BIOMARKERS, DIAGNOSTICS: CSF, BLOOD, BODY FLUID BIOMARKERS1
SHIFT 01 - VIRTUAL ORAL: THEME B: TAUPATHIES / B05.I. GENETICS, EPIDEMIOLOGY: OTHER1
SHIFT 01 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C01.A. DISEASE MECHANISMS, PATHOPHYSIOLOGY: A-SYNUCLEIN AGGREGATION1
SHIFT 01 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C01.B. DISEASE MECHANISMS, PATHOPHYSIOLOGY: LRKK2, PARKIN, PINK1, DJ-11
SHIFT 01 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C02.E. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: CELL TRANSPLANTATION1
SHIFT 01 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C04.F. IMAGING, BIOMARKERS, DIAGNOSTICS: CSF, BLOOD, BODY FLUID BIOMARKERS1
SHIFT 01 - VIRTUAL ORAL: THEME H: DEMYELINATING DISEASES / H02. IMAGING, BIOMARKERS, DIAGNOSTICS1
SHIFT 01 - VIRTUAL ORAL: THEME K: PATIENT CARE AND SUPPORT / K01.G. DEMENTIA AND COGNITIVE DYFUNCTION: OTHER3
SHIFT 02 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A01.K. DISEASE MECHANISMS, PATHOPHYSIOLOGY: NEUROGENESIS2
SHIFT 02 - VIRTUAL ORAL: THEME A: Β-AMYLOID DISEASES / A04.J. IMAGING, BIOMARKERS, DIAGNOSTICS: OTHER2
SHIFT 02 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C01.C. DISEASE MECHANISMS, PATHOPHYSIOLOGY: CELL TO CELL TRANSMISSION, SPREADING OF PATHOLOGY, PRION-LIKE2
SHIFT 02 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C01.F. DISEASE MECHANISMS, PATHOPHYSIOLOGY: INFLAMMATION2
SHIFT 02 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C01.G. DISEASE MECHANISMS, PATHOPHYSIOLOGY: MICROGLIA1
SHIFT 02 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C01.N. DISEASE MECHANISMS, PATHOPHYSIOLOGY: METAL IONS1
SHIFT 02 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C01.O. DISEASE MECHANISMS, PATHOPHYSIOLOGY: MODELING OF DISEASE PROGRESSION1
SHIFT 02 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C01.P. DISEASE MECHANISMS, PATHOPHYSIOLOGY: OTHER1
SHIFT 02 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C02.D. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: DOPAMINE, ACETYLCHOLINE, NEUROTRANSMITTERS1
SHIFT 02 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C02.F. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT: ANTI-INFLAMMATORY, ANTI-OXIDANT1
SHIFT 02 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C04.A. IMAGING, BIOMARKERS, DIAGNOSTICS: STRUCTURAL MRI, MR SPECTROSCOPY1
SHIFT 02 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C04.C. IMAGING, BIOMARKERS, DIAGNOSTICS: PET3
SHIFT 02 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C04.G. IMAGING, BIOMARKERS, DIAGNOSTICS: EEG, BRAIN MAPPING, MEG2
SHIFT 02 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C04.H. IMAGING, BIOMARKERS, DIAGNOSTICS: COGNITIVE, PSYCHOMETRIC, BEHAVIORAL AND MOTOR TESTS1
SHIFT 02 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C04.I. IMAGING, BIOMARKERS, DIAGNOSTICS: OTHER2
SHIFT 02 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C05.C. GENETICS, EPIDEMIOLOGY: GWAS, GENETIC ASSOCIATIONS, SUSCEPTIBILITY & PROTECTIVE GENES1
SHIFT 02 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C06.A. CELL, MOLECULAR AND SYSTEMS BIOLOGY: A-SYNUCLEIN1
SHIFT 02 - VIRTUAL ORAL: THEME C: Α-SYNUCLEINOPATHIES / C06.D. CELL, MOLECULAR AND SYSTEMS BIOLOGY: METABOLOMICS, TRANSCRIPTOMICS, LIPIDOMICS, PROTEOMICS3
SHIFT 02 - VIRTUAL ORAL: THEME E : VASCULAR DISEASES / E03. IMAGING, BIOMARKERS, DIAGNOSTICS2
SHIFT 02 - VIRTUAL ORAL: THEME G: HUNTINGTON'S AND OTHER NEURODEGENERATIVE DISEASES / G02. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT1
SHIFT 02 - VIRTUAL ORAL: THEME G: HUNTINGTON'S AND OTHER NEURODEGENERATIVE DISEASES / G04. IMAGING, BIOMARKERS, DIAGNOSTICS1
SHIFT 02 - VIRTUAL ORAL: THEME J: PSYCHIATRIC SYMPTOMS IN NEURODEGENERATIVE DISEASES / J01. DISEASE MECHANISMS, PATHOPHYSIOLOGY2
SHIFT 02 - VIRTUAL ORAL: THEME J: PSYCHIATRIC SYMPTOMS IN NEURODEGENERATIVE DISEASES / J02. THERAPEUTIC TARGETS, MECHANISMS FOR TREATMENT1
SHIFT 02 - VIRTUAL ORAL: THEME K: PATIENT CARE AND SUPPORT / K01.C. DEMENTIA AND COGNITIVE DYFUNCTION: COGNITIVE TRAINING1
SHIFT 02 - VIRTUAL ORAL: THEME K: PATIENT CARE AND SUPPORT / K01.F. DEMENTIA AND COGNITIVE DYFUNCTION: BEHAVIORAL & PSYCHIATRIC SYMPTOMS2
SHIFT 02 - VIRTUAL ORAL: THEME K: PATIENT CARE AND SUPPORT / K02.B. MOVEMENT DISORDERS: MOTOR COORDINATION & EXERCISE1
SHIFT 02 - VIRTUAL ORAL: THEME K: PATIENT CARE AND SUPPORT / K02.D. MOVEMENT DISORDERS: QUALITY OF LIFE2
SHIFT 02 - VIRTUAL ORAL: THEME K: PATIENT CARE AND SUPPORT / K02.F. MOVEMENT DISORDERS: OTHER1
VIRTUAL E-POSTERS125
VIRTUAL ON-DEMAND ORAL IN POSTER GALLERY54

E-Poster Home
E-Poster Gallery
Name Search

Welcome to the ADPD 2024 E-Poster Gallery